Choongwae jointly to develope cancer therapy with bio company.

Published: 2007-05-10 06:56:00

Updated: 2007-05-10 06:56:00

Choongwae announced on May 7 about their strategic alliance with Goodcell Life, a subsidiary of Goodgene for a joint development of cellular therapy for cancers by use of natural killer (NK) cells.

According to the agreement, Goodcell Life transfers the patented technology of NK cell isolatio...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK